Discover 998 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 998
Optimizing Brain Stimulation Parameters
for
Epilepsy; Seizure
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 6+
Code: NCT06617845
Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Rochester MN, Madison WI, Iowa City IA, Milwaukee WI,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase1, Recruiting
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
for
Follicular Lymphoma, Marginal Zone Lymphoma
Location: Rochester MN, Rochester NY, Boston MA, Seattle WA
Sponsor: Enterome
Sex: All
Age: 18+
Code: NCT04669171
Phase1, Phase2, Recruiting
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
for
Clinical Stage I Esophageal Adenocarcinoma AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06078709
Phase2, Recruiting
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
for
Cirrhosis, Liver, Liver Fibrosis, Ascites Hepatic
Location: Rochester MN, Cleveland OH, Dallas TX, Philadelphia PA,
Sponsor: PharmaIN
Sex: All
Age: 18 - 70+
Code: NCT05490888
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
for
Bladder Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06891209
Recruiting
Stroke Thrombectomy and Aneurysm Registry
for
Stroke, Thromboses, Intracranial, Aneurysm, Brain
Location: Rochester MN, Iowa City IA, Evanston IL, Chicago IL,
Sponsor: Medical University of South Carolina
Sex: All
Age: 1 - 70+
Code: NCT04994756
Recruiting
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
Location: Rochester MN, Toronto, Montreal, New York NY,
Sponsor: Mayo Clinic
Sex: All
Age: 0+
Code: NCT06689956
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Rochester MN, Omaha NE, Chicago IL, Cleveland OH,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT03328078
Phase1, Phase2, Recruiting
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
for
Bone Sarcoma, Chondrosarcoma, Chordoma, Ewing Sarcoma of Bone,
Location: Rochester MN, Jacksonville FL, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 15+
Code: NCT05033288
Recruiting
Feasibility of a Constant Pressure Skin Disk (CPSD) in Enteral Tubes.
for
Gastrostomy
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 22+
Code: NCT03959878
Recruiting
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
for
Glioma, Glioblastoma Multiforme
Location: Rochester MN, Omaha NE
Sponsor: Aveta Biomics, Inc.
Sex: All
Age: 19+
Code: NCT06011109
Phase1, Phase2, Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Rochester MN, Madison WI, Omaha NE, Kansas City KS,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06710756
Phase1, Phase2, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Rochester MN, Minneapolis MN, Madison WI, Iowa City IA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
for
Breast Cancer, PALB2-Mutated Breast Carcinoma,
Location: Rochester MN, Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06488378
Phase1, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)